EUVIMEDEUVIMED entdecken
Crossref

18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors

Kota Kawabata, Tsuyoshi Takahashi, Toshirou Nishida, Yukinori Kurokawa, Kazuyoshi Yamamoto, Takuro Saito, Kota Momose, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Ryohei Kawabata, Atsushi Takeno und 3 weitere

Surgery Today · 2025

DOI: 10.1007/s00595-025-03029-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Kota Kawabata und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Imatinib Mesylate, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsImatinib MesylateFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyDrug Resistance, NeoplasmRadiopharmaceuticalsAntineoplastic AgentsGastrointestinal NeoplasmsHumansMaleFemalePrognosisMiddle AgedRetrospective StudiesAgedAdultAged, 80 and overSurvival Rate

Stichwörter der Autor:innen

Gastrointestinal stromal tumorImatinib resistanceMaximum standardized uptake valuePositron emission tomography-computed tomographySurgical treatment

Substanzen

Imatinib MesylateFluorodeoxyglucose F18RadiopharmaceuticalsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. ttakahashi2@gesurg.med.osaka-u.ac.jp.
  • Department of Surgery, Japan Community Healthcare Organization Osaka Hospital, 4-2-78, Fukushima, Fukushima-Ku, Osaka, Japan.
  • Department of Surgery, Sakai City Medical Center, Ebarajicho, Nishi-Ku, Sakai, Osaka, Japan.
  • Department of Surgery, NHO Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-Ku, Osaka, Japan.

Zitieren

APA

Kawabata, K., Takahashi, T., Nishida, T., Kurokawa, Y., Yamamoto, K., Saito, T., Momose, K., Yamashita, K., Tanaka, K., Makino, T., Kawabata, R., Takeno, A., Nakajima, K., Eguchi, H., & Doki, Y. (2025). 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors. Surgery Today. https://doi.org/10.1007/s00595-025-03029-7

Vancouver

Kawabata K, Takahashi T, Nishida T, Kurokawa Y, Yamamoto K, Saito T, et al. 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors. Surgery Today. 2025. doi:10.1007/s00595-025-03029-7

BibTeX
@article{Kawabata2025,
  author = {Kawabata, Kota and Takahashi, Tsuyoshi and Nishida, Toshirou and Kurokawa, Yukinori and Yamamoto, Kazuyoshi and Saito, Takuro and Momose, Kota and Yamashita, Kotaro and Tanaka, Koji and Makino, Tomoki and Kawabata, Ryohei and Takeno, Atsushi and Nakajima, Kiyokazu and Eguchi, Hidetoshi and Doki, Yuichiro},
  title = {18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors},
  journal = {Surgery Today},
  year = {2025},
  doi = {10.1007/s00595-025-03029-7}
}
Kostenlos starten →